- Home
- ANL vs BRSP Comparison
ANL vs BRSP Comparison
Compare ANL & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANL | BRSP |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 764.7M |
| IPO Year | 2022 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ANL | BRSP |
|---|---|---|
| Price | $14.86 | $5.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $20.00 | $6.50 |
| AVG Volume (30 Days) | ★ 677.7K | 671.8K |
| Earning Date | 04-10-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.03% |
| EPS Growth | N/A | ★ 75.24 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $330,587,000.00 |
| Revenue This Year | $36.02 | N/A |
| Revenue Next Year | N/A | $17.54 |
| P/E Ratio | ★ N/A | $193.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $4.84 |
| 52 Week High | $17.25 | $6.17 |
Technical Indicators
Market Signals| Indicator | ANL | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 49.30 |
| Support Level | $1.36 | $5.80 |
| Resistance Level | $17.25 | $6.00 |
| Average True Range (ATR) | 1.97 | 0.11 |
| MACD | -0.18 | -0.02 |
| Stochastic Oscillator | 59.34 | 20.83 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.